1
|
Bolman B. Dogs for Life: Beagles, Drugs, and Capital in the Twentieth Century. JOURNAL OF THE HISTORY OF BIOLOGY 2022; 55:147-179. [PMID: 34499296 DOI: 10.1007/s10739-021-09649-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 08/06/2021] [Indexed: 06/13/2023]
Abstract
This article tracks the transformation of beagle dogs from a common breed in mid-twentieth century American laboratories to the de jure standard in global toxicological research by the turn of the twenty-first. The breed was dispersed widely due to the expanding use of dogs in pharmacology in the 1950s and a worldwide crisis around pharmaceutical safety following the thalidomide scandal of the 1960s. Nevertheless, debates continued for decades over the beagle's value as a model of carcinogenicity, even as the dogs became legislated stand-ins for human beings in multiple countries. Situating beagles as a biocommodity, the article calls for more sustained attention to the "political economy" of laboratory organism breeding, use, and production. The story of American commercial breeder Marshall Farms offers insight into the role of for-profit companies in contemporary laboratory animal provision, as the article makes a case for the value of a global perspective on transnational corporations as key sites of scientific practice and collaboration.
Collapse
|
2
|
Ding Y, Liu H, Tekwani BL, Nanayakkara NPD, Khan IA, Walker LA, Doerksen RJ. Methemoglobinemia Hemotoxicity of Some Antimalarial 8-Aminoquinoline Analogues and Their Hydroxylated Derivatives: Density Functional Theory Computation of Ionization Potentials. Chem Res Toxicol 2016; 29:1132-41. [DOI: 10.1021/acs.chemrestox.6b00063] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Yuanqing Ding
- National Center for Natural Products Research,
Research Institute
of Pharmaceutical Science, and ‡Department of BioMolecular Sciences, School
of Pharmacy, University of Mississippi, University, Mississippi 38677, United States
| | - Haining Liu
- National Center for Natural Products Research,
Research Institute
of Pharmaceutical Science, and ‡Department of BioMolecular Sciences, School
of Pharmacy, University of Mississippi, University, Mississippi 38677, United States
| | - Babu L. Tekwani
- National Center for Natural Products Research,
Research Institute
of Pharmaceutical Science, and ‡Department of BioMolecular Sciences, School
of Pharmacy, University of Mississippi, University, Mississippi 38677, United States
| | - N. P. Dhammika Nanayakkara
- National Center for Natural Products Research,
Research Institute
of Pharmaceutical Science, and ‡Department of BioMolecular Sciences, School
of Pharmacy, University of Mississippi, University, Mississippi 38677, United States
| | - Ikhlas A. Khan
- National Center for Natural Products Research,
Research Institute
of Pharmaceutical Science, and ‡Department of BioMolecular Sciences, School
of Pharmacy, University of Mississippi, University, Mississippi 38677, United States
| | - Larry A. Walker
- National Center for Natural Products Research,
Research Institute
of Pharmaceutical Science, and ‡Department of BioMolecular Sciences, School
of Pharmacy, University of Mississippi, University, Mississippi 38677, United States
| | - Robert J. Doerksen
- National Center for Natural Products Research,
Research Institute
of Pharmaceutical Science, and ‡Department of BioMolecular Sciences, School
of Pharmacy, University of Mississippi, University, Mississippi 38677, United States
| |
Collapse
|
3
|
Liu H, Ding Y, Walker LA, Doerksen RJ. Computational Study on the Effect of Exocyclic Substituents on the Ionization Potential of Primaquine: Insights into the Design of Primaquine-Based Antimalarial Drugs with Less Methemoglobin Generation. Chem Res Toxicol 2015; 28:169-74. [PMID: 25222923 PMCID: PMC4332040 DOI: 10.1021/tx500230t] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
![]()
The effect of an
exocyclic substituent on the ionization potential
of primaquine, an important antimalarial drug, was investigated using
density functional theory methods. It was found that an electron-donating
group (EDG) makes the ionization potential decrease. In contrast,
an electron-withdrawing group (EWG) makes the ionization potential
increase. Among all the exocyclic positions, a substituent at the
5- or 7-position has the largest effect. This can be explained by
the contribution of the atomic orbitals at those positions to the
highest occupied molecular orbital (HOMO). In addition, a substituent
at the N8-position has a considerably large effect on the ionization
potential because this atom makes the second largest contribution
to the HOMO. These findings have potential implications for the design
of less hemotoxic antimalarial drugs. We suggest that it is worth
considering placement of an EWG at the 5-, 7-, or N8-positions of
primaquine in future drug discovery attempts.
Collapse
Affiliation(s)
- Haining Liu
- Department of BioMolecular Sciences and ‡the National Center for Natural Products Research, School of Pharmacy, University of Mississippi , University, Mississippi 38677, United States
| | - Yuanqing Ding
- Department of BioMolecular Sciences and ‡the National Center for Natural Products Research, School of Pharmacy, University of Mississippi , University, Mississippi 38677, United States
| | - Larry A Walker
- Department of BioMolecular Sciences and ‡the National Center for Natural Products Research, School of Pharmacy, University of Mississippi , University, Mississippi 38677, United States
| | - Robert J Doerksen
- Department of BioMolecular Sciences and ‡the National Center for Natural Products Research, School of Pharmacy, University of Mississippi , University, Mississippi 38677, United States
| |
Collapse
|
4
|
Ding Y, Liu H, Nanayakkara NPD, Khan IA, Tekwani BL, Walker LA, Doerksen RJ. Hydroxylated derivatives of NPC1161: theoretical insights into their potential toxicity and the feasibility and regioselectivity of their formation. J Phys Chem A 2014; 118:5501-7. [PMID: 24956138 PMCID: PMC4216223 DOI: 10.1021/jp502612t] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
![]()
For antimalarial 8-aminoquinoline
(8-AQ) drugs, the ionization
potential (energy required to remove an electron) of their putative
metabolites has been proposed to be correlated in part to their hemotoxicity
potential. NPC1161 is a developmental candidate as an 8-AQ antimalarial
drug. In this work, the ionization potentials (IPs) of the S-NPC1161 (NPC1161a) hydroxylated derivatives, which are
possible metabolites derived from action of endogenous cytochrome
P450 (CYP450) enzymes, were calculated at the B3LYP-SCRF(PCM)/6-311++G**//B3LYP/6-31G**
level in water. The derivative hydroxylated at N1′ (8-amino)
was found to have the smallest IP of ∼430 kJ/mol, predicting
that it would be the most hemotoxic. The calculated IPs of the derivatives
hydroxylated at the C2 and C7 positions were ∼475 and ∼478
kJ/mol, respectively, whereas the calculated IPs of those hydroxylated
at all other possible positions were between 480 and 490 kJ/mol. The
homolytic bond dissociation energies (HBDEs) of all C–H/N–H
bonds in NPC1161a were also calculated. The smaller HBDEs of the C–H/N–H
bonds on the 8-amino side chain suggest that these positions are more
easily hydroxylated compared to other sites. Molecular orbital analysis
implies that the N1′ position should be the most reactive center
when NPC1161 approaches the heme in CYP450.
Collapse
Affiliation(s)
- Yuanqing Ding
- National Center for Natural Products Research, Research Institute of Pharmaceutical Science, ‡Department of Medicinal Chemistry, §Department of Pharmacognosy, and ∥Department of Pharmacology, School of Pharmacy, University of Mississippi , University, Mississippi 38677, United States
| | | | | | | | | | | | | |
Collapse
|
5
|
Miller AK, Harrell E, Ye L, Baptiste-Brown S, Kleim JP, Ohrt C, Duparc S, Möhrle JJ, Webster A, Stinnett S, Hughes A, Griffith S, Beelen AP. Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects. Br J Clin Pharmacol 2014; 76:858-67. [PMID: 23701202 DOI: 10.1111/bcp.12160] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2012] [Accepted: 05/09/2013] [Indexed: 11/28/2022] Open
Abstract
AIMS The long-acting 8-aminoquinoline tafenoquine (TQ) coadministered with chloroquine (CQ) may radically cure Plasmodium vivax malaria. Coadministration therapy was evaluated for a pharmacokinetic interaction and for pharmacodynamic, safety and tolerability characteristics. METHODS Healthy subjects, 18-55 years old, without documented glucose-6-phosphate dehydrogenase deficiency, received CQ alone (days 1-2, 600 mg; and day 3, 300 mg), TQ alone (days 2 and 3, 450 mg) or coadministration therapy (day 1, CQ 600 mg; day 2, CQ 600 mg + TQ 450 mg; and day 3, CQ 300 mg + TQ 450 mg) in a randomized, double-blind, parallel-group study. Blood samples for pharmacokinetic and pharmacodynamic analyses and safety data, including electrocardiograms, were collected for 56 days. RESULTS The coadministration of CQ + TQ had no effect on TQ AUC0-t , AUC0-∞ , Tmax or t1/2 . The 90% confidence intervals of CQ + TQ vs. TQ for AUC0-t , AUC0-∞ and t1/2 indicated no drug interaction. On day 2 of CQ + TQ coadministration, TQ Cmax and AUC0-24 increased by 38% (90% confidence interval 1.27, 1.64) and 24% (90% confidence interval 1.04, 1.46), respectively. The pharmacokinetics of CQ and its primary metabolite desethylchloroquine were not affected by TQ. Coadministration had no clinically significant effect on QT intervals and was well tolerated. CONCLUSIONS No clinically significant safety or pharmacokinetic/pharmacodynamic interactions were observed with coadministered CQ and TQ in healthy subjects.
Collapse
|
6
|
Liu H, Tekwani BL, Nanayakkara NPD, Walker LA, Doerksen RJ. Methemoglobin generation by 8-aminoquinolines: effect of substitution at 5-position of primaquine. Chem Res Toxicol 2013; 26:1801-9. [PMID: 24224488 DOI: 10.1021/tx400067a] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Currently, the only clinically approved antimalarial drug to treat relapsing malaria is primaquine (PQ), yet PQ administration can cause life-threatening hemolytic anemia in some patients. In our efforts to understand the connection between PQ and methemoglobin formation, the effect of 5-substituted primaquine derivatives on the basicity of hemoglobin-bound O2 was investigated using various computational methods, including quantum mechanics/molecular mechanics (QM/MM) calculations, molecular dynamics simulations and density functional theory calculations, to determine the geometries, relative energies, spin densities, proton affinities and ionization potentials of various PQ derivatives and PQ···hemoglobin complexes. We found that the protein environment and solvent do not change our previously proposed methemoglobin formation mechanism that 5-hydroxyprimaquine donates an electron to O2, facilitating its conversion to H2O2 and generating methemoglobin. Because of 5-hydroxyprimaquine's ability to lose an electron by this mechanism, we then used different substituents at primaquine's 5-position and found that an electron-withdrawing group (EWG) increases the ionization potential of the corresponding derivative. As a result, the EWG-substituted derivatives make the hemoglobin-bound O2 less basic, because of their weaker electron-donating ability. These derivatives hence are predicted to have a lower propensity to generate methemoglobin, which can inform future design of less hemotoxic antimalarial drugs. We also carried out experimental measurement of methemoglobin formation for some of the 5-substituted derivatives.
Collapse
Affiliation(s)
- Haining Liu
- Department of Medicinal Chemistry, ‡National Center for Natural Products Research, and §Department of Pharmacology, University of Mississippi , University, Mississippi 38677, United States
| | | | | | | | | |
Collapse
|
7
|
Liu H, Ding Y, Walker LA, Doerksen RJ. Effect of antimalarial drug primaquine and its derivatives on the ionization potential of hemoglobin: A QM/MM study. MEDCHEMCOMM 2013; 4:1145-1147. [PMID: 23914290 PMCID: PMC3728702 DOI: 10.1039/c3md00045a] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
We used quantum mechanics/molecular mechanics calculations to test if antimalarial primaquine (PQ) and its derivatives aid the conversion of hemoglobin to methemoglobin by binding to hemoglobin and merely lowering hemoglobin's ionization potential (IP). Our results showed that PQ and its derivatives do not significantly lower the hemoglobin IP, disproving the hypothesis.
Collapse
Affiliation(s)
- Haining Liu
- Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University, MS 38677 USA
| | - Yuanqing Ding
- The National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677 USA
| | - Larry A. Walker
- The National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677 USA
- Department of Pharmacology, School of Pharmacy, University of Mississippi, University, MS 38677 USA
| | - Robert J. Doerksen
- Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University, MS 38677 USA
| |
Collapse
|
8
|
Oxidative damage to human red blood cells treated with chlorfenvinphos, an organophosphate insecticide (in vitro). Biologia (Bratisl) 2013. [DOI: 10.2478/s11756-013-0200-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
9
|
Rodrigues T, da Cruz FP, Lafuente-Monasterio MJ, Gonçalves D, Ressurreição AS, Sitoe AR, Bronze MR, Gut J, Schneider G, Mota MM, Rosenthal PJ, Prudêncio M, Gamo FJ, Lopes F, Moreira R. Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria. J Med Chem 2013; 56:4811-5. [PMID: 23701465 DOI: 10.1021/jm400246e] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We present a novel series of quinolin-4(1H)-imines as dual-stage antiplasmodials, several-fold more active than primaquine in vitro against Plasmodium berghei liver stage. Among those, compounds 5g and 5k presented low nanomolar IC50 values. The compounds are metabolically stable and modulate several drug targets. These results emphasize the value of quinolin-4(1H)-imines as a new chemotype and their suitable properties for further drug development.
Collapse
Affiliation(s)
- Tiago Rodrigues
- Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Avenida Prof. Gama Pinto, 1649-019 Lisbon, Portugal.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Rodrigues T, Prudêncio M, Moreira R, Mota MM, Lopes F. Targeting the liver stage of malaria parasites: a yet unmet goal. J Med Chem 2011; 55:995-1012. [PMID: 22122518 DOI: 10.1021/jm201095h] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Tiago Rodrigues
- Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-019 Lisbon, Portugal
| | | | | | | | | |
Collapse
|
11
|
Liu H, Walker LA, Doerksen RJ. DFT study on the radical anions formed by primaquine and its derivatives. Chem Res Toxicol 2011; 24:1476-85. [PMID: 21699254 DOI: 10.1021/tx200094v] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The electron affinities (EA) of the 8-aminoquinoline antimalarial drug primaquine and several of its metabolites were studied using the density functional theory method. We first considered six substituents at the 5-position, -CH(3), -OH, -OCH(3), -Ph, -OPh, and -CHO. We found that in the gas phase the adiabatic EAs are similar to that of the parent primaquine for the -CH(3), -OH, and -OCH(3) substituents. In contrast, the -Ph, -OPh, and -CHO substituents all markedly increase the adiabatic EA. However, only the -CHO substituted compound is predicted to form a stable covalently bound radical anion in the gas phase due to its significant positive vertical EA relative to that of the parent primaquine. In addition, when the 8-position is substituted by the N-hydroxyl group or a quinone-imine structure is formed, the electron capture ability is significantly increased. In aqueous solution, all these molecules have significantly larger adiabatic EAs than in the gas phase. In addition, all of the vertical EAs are positive in aqueous solution. The implications of these findings for contributing to our mechanistic understanding of the red cell toxicity of 8-aminoquinoline compounds are further discussed.
Collapse
Affiliation(s)
- Haining Liu
- Department of Medicinal Chemistry, University of Mississippi, Mississippi 38677, USA
| | | | | |
Collapse
|
12
|
Kaur K, Jain M, Khan SI, Jacob MR, Tekwani BL, Singh S, Singh PP, Jain R. Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines). Bioorg Med Chem 2010; 19:197-210. [PMID: 21172735 DOI: 10.1016/j.bmc.2010.11.036] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2010] [Revised: 11/16/2010] [Accepted: 11/16/2010] [Indexed: 11/17/2022]
Abstract
In continuing our search of potent antimalarials based on 8-aminoquinoline structural framework, three series of novel bis(8-aminoquinolines) using convenient one to four steps synthetic procedures were synthesized. The bisquinolines were evaluated for in vitro antimalarial (Plasmodiumfalciparum), antileishmanial (Leishmaniadonovani), antimicrobial (a panel of pathogenic bacteria and fungi), cytotoxicity, β-hematin inhibitory and methemoglobin (MetHb) formation activities. Several compounds exhibited superior antimalarial activities compared to parent drug primaquine. Selected compounds (44, 61 and 79) when tested for in vivo blood-schizontocidal antimalarial activity (Plasmodiumberghei) displayed potent blood-schizontocial activities. The bisquinolines showed negligible MetHb formation (0.2-1.2%) underlining their potential in the treatment of glucose-6-phosphate dehydrogenase deficient patients. The bisquinoline analogues (36, 73 and 79) also exhibited promising in vitro antileishmanial activity, and antimicrobial activities (43, 44 and 76) against a panel of pathogenic bacteria and fungi. The results of this study provide evidence that bis(8-aminoquinolines), like their bis(4-aminoquinolines) and artemisinin dimers counterparts, are a promising class of antimalarial agents.
Collapse
Affiliation(s)
- Kirandeep Kaur
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Sector 67, S. A. S. Nagar, Punjab 160 062, India
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Vale N, Prudêncio M, Marques CA, Collins MS, Gut J, Nogueira F, Matos J, Rosenthal PJ, Cushion MT, do Rosário VE, Mota MM, Moreira R, Gomes P. Imidazoquines as antimalarial and antipneumocystis agents. J Med Chem 2009; 52:7800-7. [PMID: 19799426 PMCID: PMC2788672 DOI: 10.1021/jm900738c] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Peptidomimetic imidazolidin-4-one derivatives of primaquine (imidazoquines) recently displayed in vitro activity against blood schizonts of a chloroquine-resistant strain of Plasmodium falciparum. Preliminary studies with a subset of such imidazoquines showed them to both block transmission of P. berghei malaria from mouse to mosquito and be highly stable toward hydrolysis at physiological conditions. This prompted us to have deeper insight into the activity of imidazoquines against both Plasmodia and Pneumocystis carinii, on which primaquine is also active. Full assessment of the in vivo transmission-blocking activity of imidazoquines, in vitro tissue-schizontocidal activity on P. berghei-infected hepatocytes, and in vitro anti-P. carinii activity is now reported. All compounds were active in these biological assays, with generally lower activity than the parent drug. However, imidazoquines' stability against both oxidative deamination and proteolytic degradation suggest that they will probably have higher oral bioavailability and lower hematotoxicity than primaquine, which might translate into higher therapeutic indexes.
Collapse
Affiliation(s)
- Nuno Vale
- CIQUP – Centro de Investigação em Química da Universidade do Porto, Departamento de Química, Faculdade de Ciências, Universidade do Porto, P-4169-007 Porto, Portugal
| | - Miguel Prudêncio
- Unidade de Malária, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, P-1649-028 Lisboa, Portugal
| | - Catarina A. Marques
- Unidade de Malária, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, P-1649-028 Lisboa, Portugal
| | - Margaret S. Collins
- Research Services, Veterans Affairs Medical Center, Cincinnati, OH 45220, USA
- Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, OH 45267-0560, USA
| | - Jiri Gut
- Department of Medicine, San Francisco General Hospital, University of California, CA 94143-0811, USA
| | - Fátima Nogueira
- Centro de Malária e Outras Doenças Tropicais, IHMT - Universidade Nova de Lisboa, P-1349-008 Lisboa, Portugal
| | - Joana Matos
- CIQUP – Centro de Investigação em Química da Universidade do Porto, Departamento de Química, Faculdade de Ciências, Universidade do Porto, P-4169-007 Porto, Portugal
| | - Philip J. Rosenthal
- Department of Medicine, San Francisco General Hospital, University of California, CA 94143-0811, USA
| | - Melanie T. Cushion
- Research Services, Veterans Affairs Medical Center, Cincinnati, OH 45220, USA
- Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, OH 45267-0560, USA
| | - Virgílio E. do Rosário
- Centro de Malária e Outras Doenças Tropicais, IHMT - Universidade Nova de Lisboa, P-1349-008 Lisboa, Portugal
| | - Maria M. Mota
- Unidade de Malária, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, P-1649-028 Lisboa, Portugal
| | - Rui Moreira
- iMed.UL, CECF, Faculdade de Farmácia, Universidade de Lisboa, P-1600-083 Lisboa, Portugal
| | - Paula Gomes
- CIQUP – Centro de Investigação em Química da Universidade do Porto, Departamento de Química, Faculdade de Ciências, Universidade do Porto, P-4169-007 Porto, Portugal
| |
Collapse
|
14
|
Zhu S, Zhang Q, Gudise C, Meng L, Wei L, Smith E, Kong Y. Synthesis and evaluation of naphthyridine compounds as antimalarial agents. Bioorg Med Chem Lett 2007; 17:6101-6. [PMID: 17900897 PMCID: PMC2072807 DOI: 10.1016/j.bmcl.2007.09.044] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2007] [Revised: 09/09/2007] [Accepted: 09/12/2007] [Indexed: 11/28/2022]
Abstract
Primaquine is the drug of choice for the radical cure of Plasmodium vivax malaria, but possesses serious side effects. In this study novel primaquine analogues were designed and synthesized. Lower toxicity was achieved by reducing or eliminating the tendency of forming chemically reactive and toxic intermediates and metabolites. In vitro and in vivo studies found that synthesized compounds were less toxic than the parent compound primaquine, while preserving the desired antimalarial activity. Some of these compounds possess a therapeutic index over 10 times superior to that of the commonly used antimalarial drug chloroquine. These compounds, as well as the underlying design rationale, may find usefulness in the discovery and development of new antimalarial drugs.
Collapse
Affiliation(s)
- Shuren Zhu
- Radix Pharmaceuticals Inc., 880 College Parkway, Rockville, MD 20850, USA.
| | | | | | | | | | | | | |
Collapse
|
15
|
Jain M, Vangapandu S, Sachdeva S, Singh S, Singh PP, Jena GB, Tikoo K, Ramarao P, Kaul CL, Jain R. Discovery of a Bulky 2-tert-Butyl Group Containing Primaquine Analogue That Exhibits Potent Blood-Schizontocidal Antimalarial Activities and Complete Elimination of Methemoglobin Toxicity. J Med Chem 2003; 47:285-7. [PMID: 14711300 DOI: 10.1021/jm0304562] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
To eliminate an unwarranted metabolic pathway of the quinoline ring, a set of two compounds, where C-2 position of the antimalarial drug primaquine is blocked by metabolically stable bulky alkyl group are synthesized. Compound 2 [R = C(CH(3))(3)] of the series has produced excellent antimalarial efficacy against P. berghei and highly virulent multidrug-resistant P. yoelii nigeriensis strain in vivo. Compound 2 was also evaluated for methemoglobin (MetHb) toxicity. This study describes the discovery of a highly potent blood-schizontocidal antimalarial analogue 2, completely devoid of MetHb toxicity.
Collapse
Affiliation(s)
- Meenakshi Jain
- National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab 160 062, India
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Rockwood GA, Armstrong KR, Baskin SI. Species comparison of methemoglobin reductase. Exp Biol Med (Maywood) 2003; 228:79-83. [PMID: 12524477 DOI: 10.1177/153537020322800111] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Methemoglobin (MHb) formation is effective in treating cyanide (CN) poisoning. Endogenous activity of the enzyme MHb reductase (MR) reflects the capacity to reduce MHb and thus represents a key factor for evaluating anti-CN efficacy of MHb formers. MR activity was measured in whole blood of nine animal species and was compared with human MR activity. The animals in this comparative study included seven nonhuman primate (NHP) species, the beagle dog, and the ferret. Although exhibiting higher MR activity than in humans, the rhesus and aotus NHPs' average MR activity was the closest to humans', with raw data from each NHP showing overlap with human raw data. The beagle dog, used extensively to study anti-CN characteristics of MHb formers, was the sole species that displayed MR activity lower than in humans, with no data overlap. Based on MR activity, the rhesus and aotus NHPs may each represent a more accurate model for predicting human responses to MHb formers. The data from this study provides a unique interspecies enzyme comparison, which should facilitate future rational development of anti-CN MHb formers.
Collapse
Affiliation(s)
- Gary A Rockwood
- Drug Assessment, Comparative Medicine, and Pharmacology Divisions, United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA.
| | | | | |
Collapse
|